1.26
price down icon3.82%   -0.05
after-market Handel nachbörslich: 1.26
loading
Schlusskurs vom Vortag:
$1.31
Offen:
$1.24
24-Stunden-Volumen:
519.12K
Relative Volume:
0.84
Marktkapitalisierung:
$131.85M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.60M
KGV:
42.00
EPS:
0.03
Netto-Cashflow:
$-62.91M
1W Leistung:
-13.70%
1M Leistung:
-24.10%
6M Leistung:
-28.81%
1J Leistung:
-47.93%
1-Tages-Spanne:
Value
$1.20
$1.335
1-Wochen-Bereich:
Value
$1.20
$1.53
52-Wochen-Spanne:
Value
$1.20
$2.66

Compugen Ltd Stock (CGEN) Company Profile

Name
Firmenname
Compugen Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
@CompugenLtd
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
CGEN's Discussions on Twitter

Vergleichen Sie CGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CGEN
Compugen Ltd
1.26 131.85M 0 1.60M -62.91M 0.03
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.56 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.78 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
550.00 33.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.95 30.15B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
220.54 25.69B 3.81B -644.79M -669.77M -6.24

Compugen Ltd Stock (CGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-13 Eingeleitet Oppenheimer Outperform
2022-08-05 Herabstufung Jefferies Buy → Hold
2020-05-26 Fortgesetzt JMP Securities Mkt Outperform
2020-05-13 Eingeleitet Stifel Buy
2020-05-07 Eingeleitet SVB Leerink Outperform
2020-04-22 Eingeleitet ROTH Capital Buy
2020-03-24 Eingeleitet SunTrust Buy
2020-01-16 Eingeleitet Cantor Fitzgerald Overweight
2018-03-29 Eingeleitet Oppenheimer Outperform
2016-02-01 Fortgesetzt Oppenheimer Outperform
2015-10-15 Eingeleitet FBR Capital Outperform
2015-04-23 Fortgesetzt Jefferies Buy
2015-04-21 Eingeleitet Oppenheimer Outperform
2014-02-07 Eingeleitet MLV & Co Buy
2009-12-28 Bestätigt Cantor Fitzgerald Buy
2009-07-29 Eingeleitet Cantor Fitzgerald Buy
Alle ansehen

Compugen Ltd Aktie (CGEN) Neueste Nachrichten

pulisher
09:55 AM

Compugen at Needham Conference: Strategic Immuno-Oncology Insights - Investing.com Australia

09:55 AM
pulisher
09:02 AM

Compugen at Needham Conference: Strategic Immuno-Oncology Insights By Investing.com - Investing.com UK

09:02 AM
pulisher
Apr 05, 2025

Compugen stock touches 52-week low at $1.35 amid market challenges - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

Compugen stock touches 52-week low at $1.35 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 03, 2025

BeiGene stock slips on trial discontinuation (ONC:NASDAQ) - Seeking Alpha

Apr 03, 2025
pulisher
Apr 02, 2025

Compugen at AI Drug Discovery Conference: Strategic Partnerships Drive Progress - Investing.com

Apr 02, 2025
pulisher
Mar 26, 2025

Cancer AI Breakthrough: Compugen Takes Center Stage at 3 Elite Healthcare Forums - Stock Titan

Mar 26, 2025
pulisher
Mar 26, 2025

Compugen to Participate in Multiple Virtual Investor Conferences in April 2025 - Yahoo Finance

Mar 26, 2025
pulisher
Mar 23, 2025

Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

Compugen Ltd. (NASDAQ:CGEN) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Reviewing Aligos Therapeutics (NASDAQ:ALGS) and Compugen (NASDAQ:CGEN) - Armenian Reporter

Mar 21, 2025
pulisher
Mar 12, 2025

Compugen at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Compugen at Leerink’s Global Healthcare Conference: Strategic Insights - Investing.com

Mar 11, 2025
pulisher
Mar 10, 2025

Oppenheimer & Co. Inc. Raises Stock Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Earnings call transcript: Compugen Q4 2024 reveals revenue decline By Investing.com - Investing.com Australia

Mar 09, 2025
pulisher
Mar 07, 2025

Compugen Ltd. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Compugen (NASDAQ:CGEN) Rating Lowered to Hold at StockNews.com - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Rodman & Renshaw maintains $4 price target on Compugen stock By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Compugen Ltd. (NASDAQ:CGEN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 05, 2025
pulisher
Mar 05, 2025

Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com

Mar 05, 2025
pulisher
Mar 04, 2025

Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings call transcript: Compugen Q4 2024 reveals revenue decline - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Rodman & Renshaw maintains $4 price target on Compugen stock - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen: Q4 Earnings Snapshot - CTPost

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen: Q4 Earnings Snapshot -March 04, 2025 at 07:23 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen Reports Fourth Quarter and Full Year 2024 Results -March 04, 2025 at 07:13 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen reports Q4 EPS (7c) vs. 11c last year - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Loss $-0.07 Per Share -March 04, 2025 at 07:08 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings Flash (CW9) COMPUGEN LTD. Posts Q4 Revenue $1.5M - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Revenue $1.5M -March 04, 2025 at 07:09 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

How Compugen's Cancer Immunotherapy Pipeline Is Advancing While Extending Cash Runway to 2027 - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

Cancer Immunotherapy Pioneer Compugen to Share Insights at Major Healthcare Conference - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference - Yahoo Finance

Mar 03, 2025
pulisher
Mar 02, 2025

Compugen (CGEN) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 02, 2025
pulisher
Feb 28, 2025

Compugen Ltd expected to post earnings of 7 cents a shareEarnings Preview - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

Compugen (CGEN) Expected to Announce Earnings on Tuesday - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Improved Revenues Required Before Compugen Ltd. (NASDAQ:CGEN) Shares Find Their Feet - Simply Wall St

Feb 26, 2025
pulisher
Feb 26, 2025

How Compugen's AI Platform Partnership Could Revolutionize Cancer Immunotherapy Discovery - StockTitan

Feb 26, 2025
pulisher
Feb 25, 2025

Compugen Ltd. Enhances its AI/ML Predictive Computational Discovery Platform, Unigen?? with Ultima Genomics' Single Cell Genomics Sequencing Technology - Marketscreener.com

Feb 25, 2025
pulisher
Feb 20, 2025

Compugen Ltd. Sets Date for Q4 2024 Financial Results Announcement - TipRanks

Feb 20, 2025
pulisher
Feb 18, 2025

Earnings Alert: Compugen Sets Date for Critical Year-End Financial Report & Strategic Update - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

Compugen: Immuno-Oncology Innovator Poised For A Comeback (NASDAQ:CGEN) - Seeking Alpha

Feb 18, 2025
pulisher
Feb 18, 2025

Compugen (NASDAQ:CGEN) Shares Cross Above 200-Day Moving Average – Time to Sell? - Defense World

Feb 18, 2025
pulisher
Feb 18, 2025

Compugen Announces Significant Share Price Increase - TipRanks

Feb 18, 2025

Finanzdaten der Compugen Ltd-Aktie (CGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$60.29
price down icon 0.48%
$68.09
price down icon 1.58%
$17.32
price down icon 0.23%
$31.03
price down icon 0.26%
$86.82
price down icon 1.40%
biotechnology ONC
$220.54
price down icon 7.53%
Kapitalisierung:     |  Volumen (24h):